William R. Shaw - 03 Aug 2021 Form 4/A - Amendment Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Former Chief Commercial Officer
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
03 Aug 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
07 Apr 2022, 17:00:23 UTC
Date Of Original Report
04 Aug 2021
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EKSO Common Stock 29,000 03 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

William R. Shaw is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On August 4, 2021, the reporting person mistakenly filed a Form 4 reporting the grant of 50,000 shares of restricted stock units that did not in fact occur. As of August 3, 2021, the reporting person owned only 29,000 shares of common stock.

Remarks:

Former Chief Commercial Officer